Lavender Aromatherapy Spine Procedure Study
Study Details
Study Description
Brief Summary
Patient anxiety prior to invasive procedures poses a significant barrier to successful treatment if not well-managed. The purpose of this study is to evaluate lavender aromatherapy, a non-sedating alternative, to reduce anxiety prior to interventional spinal procedures.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Treatment (+aromatherapy) group
|
Other: Activated Lavender Elequil aromatabs® (#372)
Activated Lavender aromatherapy tablets wrapped in tape
|
Sham Comparator: Control (-aromatherapy) group
|
Other: Unactivated Lavender Elequil aromatabs® (#372)
Unactivated Lavender aromatherapy tablets wrapped in tape
|
Outcome Measures
Primary Outcome Measures
- Change in Subjects' Anxiety State as measured by the State Trait Anxiety Inventory (STAI-6) [Administered within 30 minutes before and 30 minutes after intervention]
The STAI-6 is a six-item assessment of state anxiety. Each item is assessed on a four-point Likert scale. Scores on the STAI-6 range from 6-24, with a higher score indicating greater state anxiety.
Secondary Outcome Measures
- Number of Vasovagal Events during Standard of Care Spine Procedure [Assessed within 30 minutes following the standard of care spine procedure]
All vasovagal events that occur during the standard of care spine procedure will be recorded and reported
- Number of Aborted Standard of Care Spine Procedures [Assessed within 30 minutes following standard of care spine procedure completion or abortion]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Males and females between 18-85 years old
-
Scheduled for one of the following procedures on the day of consent:
-
Epidural steroid injection (ESI)
-
Medial branch block (MBB)
-
Radiofrequency ablation (RFA)
-
Able to provide informed consent
Exclusion Criteria:
-
History of anxiety disorder
-
Currently on anxiolytic therapy
-
Poor sense of smell
-
Allergy/aversion to aromatherapy
-
Non-English speaking
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Weill Cornell Medicine | New York | New York | United States | 10065 |
Sponsors and Collaborators
- Weill Medical College of Cornell University
Investigators
- Principal Investigator: Jaspal R Singh, MD, Weill Medical College of Cornell University
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 19-06020284